Blaess, M.;                     Kaiser, L.;                     Sauer, M.;                     Csuk, R.;                     Deigner, H.-P.    
        COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. Int. J. Mol. Sci. 2020, 21, 4953.
    https://doi.org/10.3390/ijms21144953
    AMA Style
    
                                Blaess M,                                 Kaiser L,                                 Sauer M,                                 Csuk R,                                 Deigner H-P.        
                COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. International Journal of Molecular Sciences. 2020; 21(14):4953.
        https://doi.org/10.3390/ijms21144953
    
    Chicago/Turabian Style
    
                                Blaess, Markus,                                 Lars Kaiser,                                 Martin Sauer,                                 René Csuk,                                 and Hans-Peter Deigner.        
                2020. "COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks" International Journal of Molecular Sciences 21, no. 14: 4953.
        https://doi.org/10.3390/ijms21144953
    
    APA Style
    
                                Blaess, M.,                                 Kaiser, L.,                                 Sauer, M.,                                 Csuk, R.,                                 & Deigner, H.-P.        
        
        (2020). COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. International Journal of Molecular Sciences, 21(14), 4953.
        https://doi.org/10.3390/ijms21144953